Specific variations in the USF1 gene are linked to higher fat breakdown in response to stress hormones in fat cells grown in the lab, and also to greater reduction of fat breakdown when insulin is...
Mechanism
Synthesis from 1 study
People with these specific USF1 gene versions have fat cells that respond more strongly to insulin, which means their bodies stop breaking down fat more effectively when insulin is present. This leads to less fat floating in the blood after meals. Another related effect can happen in the liver, but...
Most probable mechanism
People with certain versions of the USF1 gene have a stronger response to insulin in their fat cells. Insulin tells the fat cells to stop breaking down fat, and in these people, that signal works better because the gene makes more of a protein that controls fat breakdown. This means less fat is released into the blood when insulin is present.
USF1 transcription factor binds to promoter regions of the hormone-sensitive lipase (HSL) gene to regulate its expression.
The usf1s1 C>T and usf1s2 G>A variants increase USF1 transcriptional activity or stability in adipocytes, leading to higher baseline expression or responsiveness of HSL.
Enhanced USF1 activity increases insulin sensitivity in adipocytes, resulting in greater suppression of HSL activation during insulin stimulation.
Reduced HSL activation lowers the rate of triglyceride breakdown, decreasing free fatty acid release into circulation during insulin stimulation.
Less supported by current evidence, but not ruled out
In some people, a combination of USF1 and LIPC gene variants reduces the liver's ability to clear fat from the blood, causing more fat to build up in the liver and potentially changing how fat is handled throughout the body.
USF1 regulates expression of hepatic lipase (LIPC) in the liver.
The LIPC −514C>T SNP reduces hepatic lipase activity, decreasing hydrolysis of triglycerides in circulating lipoproteins.
Homozygosity for major USF1 alleles combined with the LIPC −514T allele leads to reduced triglyceride clearance and increased hepatic fatty acid uptake.
Accumulation of triglyceride-rich lipoproteins promotes hepatic steatosis and may alter systemic lipid availability.
Evidence from Studies
Supporting (1)
Community contributions welcome
Contradicting (0)
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.